Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review

Abstract Background Non‐melanoma skin cancers (NMSCs) are common and consume many healthcare resources. A health utility is a single preference‐based value for assessing health‐related quality of life, which can be used in economic evaluations. There are scarce data on health utilities for NMSCs. Ob...

Full description

Bibliographic Details
Main Authors: C. So, A. E. Cust, L. G. Gordon, R. L. Morton, K. Canfell, P. Ngo, M. Dieng, K. McLoughlin, C. Watts
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Skin Health and Disease
Online Access:https://doi.org/10.1002/ski2.51
id doaj-4e9044f2436e4b45a3e6970f6e3c91ea
record_format Article
spelling doaj-4e9044f2436e4b45a3e6970f6e3c91ea2021-09-01T10:51:50ZengWileySkin Health and Disease2690-442X2021-09-0113n/an/a10.1002/ski2.51Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic reviewC. So0A. E. Cust1L. G. Gordon2R. L. Morton3K. Canfell4P. Ngo5M. Dieng6K. McLoughlin7C. Watts8Sydney School of Public Health Faculty of Medicine and Health, The University of Sydney Sydney AustraliaThe Daffodil Centre The University of Sydney, a joint venture with Cancer Council NSW Sydney AustraliaPopulation Health Department QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital Brisbane AustraliaFaculty of Medicine and Health NHMRC Clinical Trials Centre, The University of Sydney Sydney AustraliaThe Daffodil Centre The University of Sydney, a joint venture with Cancer Council NSW Sydney AustraliaThe Daffodil Centre The University of Sydney, a joint venture with Cancer Council NSW Sydney AustraliaFaculty of Medicine and Health NHMRC Clinical Trials Centre, The University of Sydney Sydney AustraliaThe Daffodil Centre The University of Sydney, a joint venture with Cancer Council NSW Sydney AustraliaThe Daffodil Centre The University of Sydney, a joint venture with Cancer Council NSW Sydney AustraliaAbstract Background Non‐melanoma skin cancers (NMSCs) are common and consume many healthcare resources. A health utility is a single preference‐based value for assessing health‐related quality of life, which can be used in economic evaluations. There are scarce data on health utilities for NMSCs. Objectives Using a systematic review approach, we synthesized the current data on NMSC‐related health utilities. Methods A systematic review of studies of NMSC‐related health utilities was conducted in Medline, Embase, and Cochrane databases. Data were extracted based on the protocol and a quality assessment was performed for each study. Results The protocol resulted in 16 studies, involving 121 621 participants. Mean utility values across the studies ranged from 0.56 to 1 for undifferentiated NMSC, 0.84 to 1 for actinic keratosis, 0.45 to 1 for squamous cell carcinoma, and 0.67 to 1 for basal cell carcinoma. There was considerable variability in utilities by type of cancer, stage of diagnosis, time to treatment, treatment modality, and quality of life instrument or method. Utility values were predominantly based on the EuroQol 5‐dimension instrument and ranged from 0.45 to 0.96, while other measurement methods produced values ranging from 0.67 to 1. Lower utility values were observed for advanced cancers and for the time period during and immediately after treatment, after which values gradually returned to pre‐treatment levels. Conclusions Most utility values clustered around relatively high values of 0.8 to 1, suggesting small decrements in quality of life associated with most NMSCs and their precursors. Variability in utilities indicates that careful characterization is required for measures to be used in economic evaluations.https://doi.org/10.1002/ski2.51
collection DOAJ
language English
format Article
sources DOAJ
author C. So
A. E. Cust
L. G. Gordon
R. L. Morton
K. Canfell
P. Ngo
M. Dieng
K. McLoughlin
C. Watts
spellingShingle C. So
A. E. Cust
L. G. Gordon
R. L. Morton
K. Canfell
P. Ngo
M. Dieng
K. McLoughlin
C. Watts
Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review
Skin Health and Disease
author_facet C. So
A. E. Cust
L. G. Gordon
R. L. Morton
K. Canfell
P. Ngo
M. Dieng
K. McLoughlin
C. Watts
author_sort C. So
title Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review
title_short Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review
title_full Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review
title_fullStr Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review
title_full_unstemmed Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review
title_sort health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: a systematic review
publisher Wiley
series Skin Health and Disease
issn 2690-442X
publishDate 2021-09-01
description Abstract Background Non‐melanoma skin cancers (NMSCs) are common and consume many healthcare resources. A health utility is a single preference‐based value for assessing health‐related quality of life, which can be used in economic evaluations. There are scarce data on health utilities for NMSCs. Objectives Using a systematic review approach, we synthesized the current data on NMSC‐related health utilities. Methods A systematic review of studies of NMSC‐related health utilities was conducted in Medline, Embase, and Cochrane databases. Data were extracted based on the protocol and a quality assessment was performed for each study. Results The protocol resulted in 16 studies, involving 121 621 participants. Mean utility values across the studies ranged from 0.56 to 1 for undifferentiated NMSC, 0.84 to 1 for actinic keratosis, 0.45 to 1 for squamous cell carcinoma, and 0.67 to 1 for basal cell carcinoma. There was considerable variability in utilities by type of cancer, stage of diagnosis, time to treatment, treatment modality, and quality of life instrument or method. Utility values were predominantly based on the EuroQol 5‐dimension instrument and ranged from 0.45 to 0.96, while other measurement methods produced values ranging from 0.67 to 1. Lower utility values were observed for advanced cancers and for the time period during and immediately after treatment, after which values gradually returned to pre‐treatment levels. Conclusions Most utility values clustered around relatively high values of 0.8 to 1, suggesting small decrements in quality of life associated with most NMSCs and their precursors. Variability in utilities indicates that careful characterization is required for measures to be used in economic evaluations.
url https://doi.org/10.1002/ski2.51
work_keys_str_mv AT cso healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview
AT aecust healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview
AT lggordon healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview
AT rlmorton healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview
AT kcanfell healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview
AT pngo healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview
AT mdieng healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview
AT kmcloughlin healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview
AT cwatts healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview
_version_ 1721182755994206208